Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Interferon Therapy (HCV)
Serum Gamma-GT/ALT May Show IFN Response
September 6th, 1999
Serum gamma-glutamyltransferase/alanine transferase ratio may be a good indicator of response to interferon in chronic hepatitis C patients. Chronic hepatitis C virus (HCV) infection in humans is treated at present with interferon (IFN)-alpha. Because the proportion of patients responding to therapy with sustained or even just with transient elimination of viral RNA is low, several potential prognostic parameters have been evaluated to predict the outcome of the therapy. In this study, S. Mihm and colleagues from Germany's Georg-August-Universitat sought to prove the validity of a predictive parameter described previously for initial virological...
Source: Hepatitis Weekly (1999-09-06)
|
